Bamco Inc. NY trimmed its position in Maximus, Inc. (NYSE:MMS) by 0.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,107,011 shares of the health services provider’s stock after selling 26,205 shares during the quarter. Maximus comprises 1.0% of Bamco Inc. NY’s holdings, making the stock its 24th largest position. Bamco Inc. NY owned approximately 4.79% of Maximus worth $200,402,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Acrospire Investment Management LLC grew its holdings in Maximus by 17.6% during the second quarter. Acrospire Investment Management LLC now owns 2,000 shares of the health services provider’s stock worth $125,000 after acquiring an additional 300 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Maximus by 10.2% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,367 shares of the health services provider’s stock worth $148,000 after acquiring an additional 220 shares during the period. Intl Fcstone Inc. acquired a new stake in Maximus in the second quarter valued at approximately $201,000. GW Henssler & Associates Ltd. acquired a new stake in Maximus in the second quarter valued at approximately $205,000. Finally, OLD National Bancorp IN acquired a new stake in Maximus in the third quarter valued at approximately $246,000. Hedge funds and other institutional investors own 94.82% of the company’s stock.
MMS has been the topic of several research analyst reports. Zacks Investment Research lowered Maximus from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Robert W. Baird reissued a “hold” rating and issued a $64.00 price objective on shares of Maximus in a report on Friday, September 1st. Finally, Canaccord Genuity dropped their price objective on Maximus from $62.00 to $61.00 and set a “hold” rating on the stock in a report on Friday, November 10th. Two research analysts have rated the stock with a sell rating and six have assigned a hold rating to the company. The company presently has an average rating of “Hold” and an average price target of $64.33.
In other news, CEO Richard A. Montoni sold 30,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 7th. The stock was sold at an average price of $69.25, for a total value of $2,077,500.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, General Counsel David Francis sold 1,373 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $65.35, for a total value of $89,725.55. Following the completion of the transaction, the general counsel now owns 13,617 shares in the company, valued at approximately $889,870.95. The disclosure for this sale can be found here. In the last 90 days, insiders sold 103,717 shares of company stock worth $6,966,735. Company insiders own 3.10% of the company’s stock.
Maximus, Inc. (NYSE MMS) traded up $0.68 during midday trading on Monday, hitting $70.82. The stock had a trading volume of 420,400 shares, compared to its average volume of 359,100. The stock has a market capitalization of $4,612.97, a P/E ratio of 22.77, a PEG ratio of 2.66 and a beta of 1.35. Maximus, Inc. has a 1-year low of $51.74 and a 1-year high of $70.83.
The company also recently announced a quarterly dividend, which was paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th were given a $0.045 dividend. The ex-dividend date was Tuesday, November 14th. This represents a $0.18 annualized dividend and a dividend yield of 0.25%. Maximus’s dividend payout ratio (DPR) is presently 5.66%.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.